{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:27:39Z","timestamp":1794425259450,"version":"4.9.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93023C00040"],"award-info":[{"award-number":["75N93023C00040"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93024C00020"],"award-info":[{"award-number":["75N93024C00020"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI168643"],"award-info":[{"award-number":["U19AI168643"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.coviro.2026.101557","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:15:11Z","timestamp":1780445711000},"page":"101557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Use of age-specific human in vitro platforms to advance discovery and development of novel vaccine adjuvants"],"prefix":"10.1016","volume":"76","author":[{"given":"Sanya","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-1945","authenticated-orcid":false,"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2026.101557_bib1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2021.42.210065","article-title":"The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: implications for COVID-19 vaccination. How can we do better?","volume":"42","author":"Frenkel","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.coviro.2026.101557_bib2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jcpa.2007.04.004","article-title":"The challenges of vaccine responses in early life: selected examples","volume":"137","author":"Siegrist","year":"2007","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.coviro.2026.101557_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00532","article-title":"Neonatal immunization: rationale, current state, and future prospects","volume":"9","author":"Whittaker","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_sbref4","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2477300","article-title":"Age-related changes in the immune system and challenges for the development of age-specific vaccines","volume":"57","author":"Doherty","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.coviro.2026.101557_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2012.02.042","article-title":"Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways","volume":"130","author":"Philbin","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02634","article-title":"Microphysiologic human tissue constructs reproduce autologous age-specific BCG and HBV primary immunization in vitro","volume":"9","author":"Sanchez-Schmitz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.immuni.2023.02.013","article-title":"Programmed and environmental determinants driving neonatal mucosal immune development","volume":"56","author":"Torow","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2026.101557_bib8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/1744666X.2014.942288","article-title":"Immune responses in neonates","volume":"10","author":"Basha","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00457","article-title":"Soluble mediators regulating immunity in early life","volume":"5","author":"Pettengill","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2026.101557_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ni0311-189","article-title":"Challenges in infant immunity: implications for responses to infection and vaccines","volume":"12","author":"PrabhuDas","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01249","article-title":"Neonatal immunity, respiratory virus infections, and the development of asthma","volume":"9","author":"Restori","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/microorganisms12040775","article-title":"The impact of immune system aging on infectious diseases","volume":"12","author":"Quiros-Roldan","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.coviro.2026.101557_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00717","article-title":"Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives","volume":"11","author":"Wagner","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.immuni.2015.11.012","article-title":"Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures","volume":"43","author":"Nakaya","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2026.101557_bib16","first-page":"98","article-title":"Influenza vaccination: accelerating the process for new vaccine development in older adults","volume":"43","author":"McElhaney","year":"2020","journal-title":"Inter Top Gerontol Geriatr"},{"key":"10.1016\/j.coviro.2026.101557_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season","volume":"71","author":"Grohskopf","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.coviro.2026.101557_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.molmed.2022.09.008","article-title":"How aging impacts vaccine efficacy: known molecular and cellular mechanisms and future directions","volume":"28","author":"Chen","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.coviro.2026.101557_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101557_bib20","article-title":"Dose-sparing effects of novel adjuvants and aluminum hydroxide on two different vaccines in a neonatal mouse model","volume":"16","author":"Estupi\u00f1an","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00418-0","article-title":"\u201cWorld in motion\u201d \u2013 emulsion adjuvants rising to meet the pandemic challenges","volume":"6","author":"O\u2019Hagan","year":"2021","journal-title":"npj Vaccin"},{"key":"10.1016\/j.coviro.2026.101557_bib22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coviro.2026.101557_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1043109","article-title":"New-age vaccine adjuvants, their development, and future perspective","volume":"14","author":"Verma","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102189","article-title":"Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants","volume":"77","author":"Lee","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01172-3","article-title":"Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections","volume":"10","author":"Taquet","year":"2025","journal-title":"npj Vaccin"},{"key":"10.1016\/j.coviro.2026.101557_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.coviro.2026.101557_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4049\/jimmunol.174.3.1259","article-title":"Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8","volume":"174","author":"Gorden","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2189885","article-title":"The Matrix-M\u2122 adjuvant: a critical component of vaccines for the 21(st) century","volume":"19","author":"Stertman","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coviro.2026.101557_bib30","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.vaccine.2022.07.030","article-title":"CpG 1018\u00ae adjuvant enhances Tdap immune responses against Bordetella pertussis in mice","volume":"40","author":"DeJong","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2026.101557_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq7378","article-title":"Precision adjuvants for pediatric vaccines","volume":"16","author":"Singh","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2026.101557_sbref32","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240961","article-title":"Vaccinology: getting our modernization act together","volume":"222","author":"Levy","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101557_sbref33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2023.11.002","article-title":"Modeling human immune responses to vaccination in vitro","volume":"45","author":"Morrocchi","year":"2024","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1584852","article-title":"Methods integrating innate and adaptive immune responses in human in vitro immunization assays","volume":"16","author":"Bowley","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-020-01145-0","article-title":"Modeling human adaptive immune responses with tonsil organoids","volume":"27","author":"Wagar","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2026.101557_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2518641","article-title":"Innovative micro physiological systems for vaccine development","volume":"21","author":"Reynaud","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coviro.2026.101557_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174144","article-title":"Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent","volume":"134","author":"Stylianou","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2026.101557_sbref38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg3747","article-title":"From hit to vial: precision discovery and development of an imidazopyrimidine TLR7\/8 agonist adjuvant formulation","volume":"10","author":"Soni","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.coviro.2026.101557_sbref39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66878-3","article-title":"Discovery of a small molecule TLR3 agonist adjuvant","volume":"17","author":"Lee","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2026.101557_sbref40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168446","article-title":"Human in vitro modeling identifies adjuvant combinations that unlock antigen cross-presentation and promote T-helper 1 development in newborns, adults and elders","volume":"436","author":"Thomas","year":"2024","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coviro.2026.101557_sbref41","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-025-08582-y","article-title":"Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screening","volume":"8","author":"Kadivella","year":"2025","journal-title":"Commun Biol"},{"key":"10.1016\/j.coviro.2026.101557_bib42","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.vaccine.2017.01.053","article-title":"A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response","volume":"35","author":"Probst","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2026.101557_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-024-00810-6","article-title":"The scientific journey of a novel adjuvant (AS37) from bench to bedside","volume":"9","author":"D\u2019Oro","year":"2024","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coviro.2026.101557_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701445","article-title":"Small molecule potentiator of adjuvant activity enhancing survival to influenza viral challenge","volume":"12","author":"Saito","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-06390-4","article-title":"Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro","volume":"7","author":"Sch\u00fcller","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.coviro.2026.101557_bib46","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1093\/jimmun\/vkaf262","article-title":"Deep phenomics of PRR agonist activated human blood","volume":"214","author":"Barman","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000545432","article-title":"Patients hospitalized with COVID-19 demonstrate distinct plasma cytokine and chemokine concentrations in vivo and TLR-mediated cytokine and chemokine production in whole blood in vitro","volume":"17","author":"Nguyen","year":"2025","journal-title":"J Innate Immun"},{"key":"10.1016\/j.coviro.2026.101557_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111055","article-title":"The BNT162b2 mRNA vaccine demonstrates reduced age-associated T(H)1 support in vitro and in vivo","volume":"27","author":"Brook","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.coviro.2026.101557_bib49","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.4049\/jimmunol.1600282","article-title":"Age-specific adjuvant synergy: dual TLR7\/8 and mincle activation of human newborn dendritic cells enables Th1 polarization","volume":"197","author":"Haren","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00759-y","article-title":"Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen","volume":"8","author":"Doss-Gollin","year":"2023","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coviro.2026.101557_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103119","article-title":"T-B coculture assay for functional analysis of antigen-specific memory CD4(+) T cells","volume":"5","author":"Ansari","year":"2024","journal-title":"STAR Protoc"},{"key":"10.1016\/j.coviro.2026.101557_bib52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.1600318","article-title":"A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4+ T cells in blood","volume":"197","author":"Dan","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib53","doi-asserted-by":"crossref","DOI":"10.1063\/5.0247363","article-title":"Interstitial fluid flow in an engineered human lymph node stroma model modulates T cell egress and stromal change","volume":"9","author":"Hammel","year":"2025","journal-title":"APL Bioeng"},{"key":"10.1016\/j.coviro.2026.101557_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlaf075","article-title":"Screening for next generation vaccines in human immune organoids","volume":"9","author":"Chen","year":"2025","journal-title":"Immunohorizons"},{"key":"10.1016\/j.coviro.2026.101557_bib55","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240289","article-title":"Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting","volume":"221","author":"Jeger-Madiot","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101557_bib56","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN\u03b3 response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coviro.2026.101557_bib59","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2026.101557_bib60","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2026.101557_bib61","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.172.2.954","article-title":"IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA","volume":"172","author":"Wagner","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib62","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib63","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1073\/pnas.1400476111","article-title":"Systems vaccinology: probing humanity\u2019s diverse immune systems with vaccines","volume":"111","author":"Pulendran","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2026.101557_bib64","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4049\/jimmunol.2300185","article-title":"A predictive model of vaccine reactogenicity using data from an in vitro human innate immunity assay system","volume":"212","author":"Pullen","year":"2024","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2026.101557_sbref65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41590-024-02036-z","article-title":"System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans","volume":"26","author":"Cortese","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay4014","article-title":"The science and medicine of human immunology","volume":"369","author":"Pulendran","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101557_bib67","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41590-022-01329-5","article-title":"Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination","volume":"23","author":"Fourati","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib68","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","article-title":"Variation in the human immune system is largely driven by non-heritable influences","volume":"160","author":"Brodin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2026.101557_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-02198-6","article-title":"AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential","volume":"9","author":"Ma","year":"2025","journal-title":"npj Digit Med"},{"key":"10.1016\/j.coviro.2026.101557_bib71","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2016.12.985","article-title":"Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses","volume":"140","author":"Dowling","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91020","article-title":"TLR7\/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth","volume":"2","author":"Dowling","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2026.101557_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/immunohorizons.1700063","article-title":"Recent advances in the discovery and delivery of TLR7\/8 agonists as vaccine adjuvants","volume":"2","author":"Dowling","year":"2018","journal-title":"Immunohorizons"},{"key":"10.1016\/j.coviro.2026.101557_bib74","article-title":"Ectopic lymphoid follicle formation and human seasonal influenza vaccination responses recapitulated in an organ-on-a-chip","volume":"9","author":"Goyal","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.coviro.2026.101557_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/micronano.2016.22","article-title":"Multi-analyte biosensor interface for real-time monitoring of 3D microtissue spheroids in hanging-drop networks","volume":"2","author":"Misun","year":"2016","journal-title":"Microsyst Nanoeng"},{"key":"10.1016\/j.coviro.2026.101557_bib76","first-page":"E2293","article-title":"Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2026.101557_bib77","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/jpm12020166","article-title":"Computational models for clinical applications in personalized medicine-guidelines and recommendations for data integration and model validation","volume":"12","author":"Collin","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.coviro.2026.101557_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1654060","article-title":"Machine learning insights into vaccine adjuvants and immune outcomes","volume":"16","author":"Ji","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101557_bib79","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/21645515.2019.1670035","article-title":"Computational tools for modern vaccine development","volume":"16","author":"Sunita","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coviro.2026.101557_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1502484","article-title":"Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions","volume":"16","author":"Anderson","year":"2025","journal-title":"Front Immunol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625726000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625726000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:20:16Z","timestamp":1794424816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625726000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":80,"alternative-id":["S1879625726000490"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2026.101557","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of age-specific human in vitro platforms to advance discovery and development of novel vaccine adjuvants","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2026.101557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101557"}}